David Risinger's Stock Ratings

Leerink Partners Analyst

David Risinger is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 02/15/2025

Overall Average Return

15.5%

Smart Score

Overall Average Return Percentile

71st

Number of Ratings

228

Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

A Glimpse Into The Expert Outlook On AbbVie Through 15 Analysts

Deep Dive Into Bristol-Myers Squibb Stock: Analyst Perspectives (9 Ratings)

Where Johnson & Johnson Stands With Analysts

Assessing AbbVie: Insights From 17 Financial Analysts

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

What 25 Analyst Ratings Have To Say About Regeneron Pharmaceuticals

Analyst Scoreboard: 19 Ratings For AbbVie

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields

This Elastic Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

The Best Trading Research Platform

For Retail Investors and Professional Trades Alike.

Get Started for Free

Benzinga Pro on Macbook